key: cord-0954855-ywf4m6ku
authors: Márquez, Sully; Prado-Vivar, Belén; Guadalupe, Juan José; Gutierrez, Bernardo; Becerra-Wong, Mónica; Jibaja, Manuel; Tobar, Milton; Barragán, Verónica; Rojas-Silva, Patricio; Coloma, Josefina; Trueba, Gabriel; Grunauer, Michelle; Cárdenas, Paúl
title: Metagenome of a Bronchoalveolar Lavage Fluid Sample from a Confirmed COVID-19 Case in Quito, Ecuador, Obtained Using Oxford Nanopore MinION Technology
date: 2020-10-08
journal: Microbiol Resour Announc
DOI: 10.1128/mra.00996-20
sha: 4639982991415748b97d7ff5e381363430cb422c
doc_id: 954855
cord_uid: ywf4m6ku

We report the metagenome analysis of a bronchoalveolar lavage (BAL) fluid sample from a confirmed coronavirus disease 2019 (COVID-19) case in Quito, Ecuador. Sequencing was performed using MinION technology.

M etagenome analysis could be relevant in critically ill coronavirus disease 2019 (COVID-19) patients. These data can help identify coinfections and provide information for optimal treatment. We collected a sample of bronchoalveolar lavage (BAL) fluid from a confirmed COVID-19 case in Quito, Ecuador (HEE1). The patient, a tourist of Dutch origin in his late 50s, presented respiratory symptoms, including fever and cough, during a visit to Sucumbios Province in Ecuador's Amazon region. He was admitted with paroxysmal coughing to a public hospital in Lago Agrio, Ecuador, and an initial diagnosis of bacterial pneumonia was made. Diagnosis of COVID-19 was confirmed by the Ecuadorian Ministry of Health on 7 March 2020. Because the patient's condition deteriorated, he was transferred to the Eugenio Espejo Hospital (HEE) intensive care unit (ICU) in Quito, Ecuador. On 11 March, a nonbronchoscopic protected BAL was performed using the double-catheter technique (the amount of aspirated fluid was 7 ml), and the sample was immediately transported for analysis. Sample positivity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was confirmed with reverse transcription-quantitative PCR (RT-PCR) using the Veri-Q PCR 316 kit (MiCo BioMed, South Korea) that targets the ORF3a and N genes; the test came back positive for gene ORF3a with a quantification cycle (C q ) value of 32.59. The patient recovered after 1 month of hospitalization and returned to his native country on 10 April.

Metagenome sequencing of the BAL sample was carried out using Oxford Nanopore MinION technology. Total RNA was extracted from 250 ml of the BAL sample using a QIAamp viral RNA extraction kit (Qiagen, Germany) following the manufacturer's instructions; no DNase digestion step was added. The sample was eluted in a final volume of 70 ml. Extracted RNA was purified using the RNA Clean and Concentrator kit (Zymo Research, USA). Purified RNA (14 ml) was used for retrotranscription of RNA to cDNA following the RNA Viral Metagenomics MinION one-pot sequencing protocol from the genomics department of Public Health England (1, 2). Taxonomic classification of the sequences was performed using the Kaiju platform (4). Metagenome analysis yielded a total of 206,111 DNA sequences with 43,603,091 bases and a read length N 50 value of 263 bp. Viral sequences represented 0.9% of the total metagenome, 4% of which corresponded to Coronavirinae. In this group, 83% represented nonassigned coronaviruses, and 17% were identified as SARS coronaviruses (Fig. 1A) . Additionally, several bacterial and eukaryotic sequences related to the patient's respiratory microbiota were identified. The most relevant taxa found were Streptococcus pneumoniae (7%), Chlamydia spp. (5%), Mycobacterium tuberculosis (4%), and Staphylococcus aureus (3%). We did not identify any particular clinically relevant fungus.

A 3,173-bp SARS-CoV-2 consensus sequence was obtained by mapping reads against the reference strain Wuhan-Hu-1 (GenBank accession number MN908947) using minimap2 version 2.14-r883 (5) . Samtools version 1.9 (http://samtools.github.io) and Tablet alignment viewer version 1.19.09.3 (https://ics.hutton.ac.uk/tablet) were used to visualize the mapped sequence. A sequence similarity of 99.68% was found with ORF1AB, with 100% coverage. To confirm taxonomic classification, a phylogenetic tree (Fig. 1B) was inferred by using the maximum likelihood method and the Tamura-Nei model with MEGA X (6). The sequences used to build the phylogenetic tree included the ORF1AB gene sequence recovered from the metagenome analysis and the sequences of 7 SARS-CoV-2 strains and the closely related bat coronavirus strain RaTG13 (Fig. 1B) from GenBank NCBI (www.ncbi.nlm.nih.gov). All bioinformatic tools were run with default parameters.

Ethical approval for using the sample was given by CEISH-USFQ (Comité de Ética de Investigación en Seres Humanos-USFQ) (IE-JP067-2020-CEISH-USFQ).

Data availability. The metagenome sequences are publicly available at accession number PRJNA613094 (Fastq for called reads, SRR11341345; raw Fast5, SRR12664395).

Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis

Assessment of metagenomic Nanopore and Illumina sequencing for recovering whole genome sequences of chikungunya and dengue viruses directly from clinical samples

NanoPack: visualizing and processing long-read sequencing data

Fast and sensitive taxonomic classification for metagenomics with Kaiju

minimap2: pairwise alignment for nucleotide sequences

MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms

This work was funded by Universidad San Francisco de Quito and supported by the Centre for Arbovirus Discovery, Diagnostics, Genomics, and Epidemiology (CADDE) (www.caddecentre.org/). P.C. is funded by NIH FIC D43TW010540 Global Health Equity Scholars. B.G. is supported by the SENESCYT Scholarship Program (ARSEQ-BEC-003163 -2017).